Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
The DOI matches its Crossref record.
Abstract
Micro- and macrovascular complications are major causes of disability and death in patients with diabetes mellitus. Functional impairment of endothelial activity precedes the development of morphological alterations during the progression of diabetes. This endothelial dysfunction results from reduced bioavailability of the vasodilator nitric oxide (NO), mainly due to accelerated NO degradation by reactive oxygen species (ROS). Although hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia independently contribute to endothelial dysfunction via several distinct mechanisms, increased oxidative stress seems to be the first alteration triggering several others. Mechanisms proposed to explain glucose- and lipid-induced vascular alterations in diabetes include accelerated formation of advanced glycation end-products (AGEs), protein kinase C activation, inflammatory signaling and oxidative stress. Insulin resistance with impaired PI 3-kinase effects decreases insulin mediated production of NO and reduces vasodilation, capillary recruitment and antioxidant properties of endothelium. Compensatory hyperinsulinemia enhances activation of intact MAP-kinase pathways and contributes to pro-atherogenic events by increasing secretion of endothelin-1 (ET-1), stimulating expression of adhesion molecules such as VCAM-1 and E-selectin, and inducing production of ROS. Conventional therapies to reduce hyperglycemia, dyslipidemia and insulin resistance may effectively improve endothelial function and delay the onset of vascular complications. Novel therapeutic approaches designed to inhibit AGEs formation, reduce PKC activation, decrease inflammatory signals and restore the ox/redox balance of endothelium may be predicted to ameliorate vascular function in diabetic state. This review summarizes the current knowledge on the most important mechanisms involved in endothelial dysfunction during diabetes. In addition, novel therapeutic strategies that may result from recently identified targets are also described.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [29]
Citations
Cites
Still being checked.
Cited by
Items 201–280 of 280
Azra, J. M., Setiawan, B., Nasution, Z., Sulaeman, A., & Estuningsih, S. (2023) · Amerta Nutrition · doi:10.20473/amnt.v7i2.2023.317-325 · Cited by 4
Clinical determinants of carotid intima-media thickness in patients with diabetes mellitus type 2
Bartman, W., & Pierzchała, K. (2012) · Neurologia i Neurochirurgia Polska · doi:10.5114/ninp.2012.32278 · Cited by 4
Taye, A., & Wind, S. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Red Blood Cells Surface Morphology in Diabetic Ketoacidosis
Kholoussi, N. M., Helwa, I., Amara, F., Baskurt, O. K., Megalaa, M., Korani, M., & Amara, M. E. O. (2012) · Cited by 4
Cerebrovascular Disease in Type 1 Diabetes: Role of Oxidative Stress
Arrick, D. M., & Mayhan, W. G. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4899-8035-9_2 · Cited by 4
Key profibrotic and pro-inflammatory pathways in the pathogenesis of diabetic kidney disease
Patel, D. M., Yang, Y., Shi, K., Wu, T., Cooper, M. E., & Chai, Z. (2021) · Diabetic Nephropathy · doi:10.2478/dine-2021-0005 · Cited by 4
Jarrett, C. L., Ahmed, Z., Faust, J. J., & Sweazea, K. L. (2016) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2016.07.010 · Cited by 4
Effect of indomethacin on cerebrovascular reactivity in patients with type 2 diabetes mellitus
Vuletić, V., Drenjančević, I., Rahelić, D., & Demarin, V. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.004 · Cited by 4
Cellular and Functional Effects of Insulin Based Therapies and Exercise on Endothelium
Luse, M. A., Heiston, E. M., Malin, S. K., & Isakson, B. E. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200721002735 · Cited by 4
Diabetic Kidney Disease: From Pathophysiology to Treatment Perspectives
Varda, L., Vreča, N., Ekart, R., Bevc, S., & Piko, N. (2026) · Kidney & Blood Pressure Research · doi:10.1159/000550085 · Cited by 15
Abramo, T. J., Szlam, S. M., Hargrave, H., Harris, Z. L., Williams, A. M., Meredith, M. L., Hedrick, M., Hu, Z., Nick, T. G., & Gonzalez, C. V. (2019) · Pediatric Emergency Care · doi:10.1097/pec.0000000000001774 · Cited by 3
Aktuelles zur diabetischen Makroangiopathie
Kunz, J. (2012) · Der Pathologe · doi:10.1007/s00292-011-1554-8 · Cited by 4
Rajsfus, B. F., Júnior, J. X. D. N., Chichierchio, M. S., Todeschini, A. R., Oliveira, I. D. A., Borges, F. D. S., Barroso, S. P. C., Mohana‐Borges, R., Pereira, J. L., Zancan, P., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123729 · Cited by 3
Merani, S., McCall, M., Pawlick, R. L., Edgar, R. L., Davis, J., Toso, C., Emamaullee, J. A., Kin, T., & Shapiro, A. M. J. (2011) · Islets · doi:10.4161/isl.3.6.17766 · Cited by 3
Salini, D. M. A., & Gp, J. (2014) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2014.i06.07 · Cited by 3
Bashar, T., & Akhter, N. (2015) · University Heart Journal · doi:10.3329/uhj.v10i2.26122 · Cited by 3
Endothelin-1-Induced Endoplasmic Reticulum Stress in Parkinson's Disease
Jain, A., Migdalska‐Richards, A., & Jain, A. (2014) · Pharmacologia · doi:10.5567/pharmacologia.2014.84.90 · Cited by 3
Crespo, M. J., Román, M., Matias, J., Morales, M., Torres, H., & Quidgley, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/9790303 · Cited by 3
Uwaezuoke, S. N., & Ayuk, A. C. (2020) · EMJ Nephrology · doi:10.33590/emjnephrol/20-00077 · Cited by 4
Pamu, D., Ayyamperumal, S., Munikumar, M., Tallapaneni, V., Nanjan, C. M. J., & Karri, V. V. S. R. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.118396 · Cited by 2
Yen, S., Wang, Y., & Liao, L. (2024) · iScience · doi:10.1016/j.isci.2024.110108 · Cited by 4
Ayça, B., Yıldız, C., Yüksel, Y., Katkat, F., Arpaç, A., Çağlar, F. N. T., & Erkol, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237271 · Cited by 3
Ugwueze, C. V. (2025) · Journal of Diabetology · doi:10.4103/jod.jod_101_24 · Cited by 4
Is there a paradigm shift in preventing diabetic heart failure? A review of SGLT2 inhibitors
KHAKDE, S., Jawaid, H., Yasmin, F., Ali, M. B., & REHMAN, A. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03221-6 · Cited by 2
Role of endothelial progenitor cells in diabetes mellitus
Avogaro, A., & Fadini, G. P. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.49 · Cited by 2
Todirita, A., Manea, A., & Manea, S. (2013) · Cited by 2
Sekundäre Neuroprotektion beim Glaukom durch ergänzende medikamentöse Therapiekonzepte
Erb, C. (2020) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1093-0945 · Cited by 3
Marcel, S., Abid, A., Vesa, C. M., Aron, R. A. C., Ghitea, T. C., Angelescu, G. A., & Popa, A. R. (2021) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2021.56.1.12 · Cited by 2
Endoglin: a novel predictor of vascular complications in type 1 diabetic children and adolescents
El-Kassas, G. M., Wakeel, M. A. E., Helal, R., Amer, A., Batal, W. H. E., Mohammed, N. A. G., & Amer, M. (2017) · Journal of The Arab Society for Medical Research · doi:10.4103/jasmr.jasmr_20_17 · Cited by 2
Singh, S., Pavan, M. K., Barella, L. F., Telang, J., Shree, A., Agarwal, S., Goel, A., Thaleshwari, S., Wess, J., Zafar, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656754 · Cited by 2
Guo, Y., Zhao, L., Zhu, L., Wang, L., & Dong, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s537949 · Cited by 1
Yilmaz, A., & Eyiol, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020872 · Cited by 4
Exerkines in diabetic retinopathy: from mechanisms to therapeutic prospects
Zhu, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1762255 · Cited by 1
Lu, F., & Yang, F. (2026) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2026.108639 · Cited by 1
Singh, S., Pavan, M. K., BARELLA, L. F., Telang, J., Shree, A., Agarwal, S., Goel, A., Thaleshwari, S., Wess, J., Zafar, H., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102387 · Cited by 5
Myovascular Niche: The Role of Endothelial Cells in Skeletal Muscle Health and Disease
Kashaniasl, Z., Molaei, D. D., Liu, M., Chatterjee, S., Razmjoo, H., & Darabi, R. (2026) · Circulation Research · doi:10.1161/circresaha.126.328678 · Cited by 2
Zhang, R., Zhang, Y., Lu, C., Fan, K., Wang, H., Wang, Q., Ning, Y., Li, Y., Zhang, Z., Jia, X., et al. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70169 · Cited by 1
Ekşi, Y. E., Karaali, Z., Incekara, K., & Ergen, A. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2013-0022 · Cited by 1
Cell and Tissue Destruction in Selected Disorders
Arnhold, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816388-7.00009-7 · Cited by 1
Cuţaş, A., Drugan, C., Román, G., Rusu, A., Istrate, D., Achimaş-Cadariu, A., & Drugan, T. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00824-5 · Cited by 2
Adejare, A. A., Oloyo, A. K., Ishola, I. O., Busari, A. A., Ismail-Badmus, K., & Abdulrazaq, M. M. (2023) · Journal of African Association of Physiological Sciences · doi:10.4314/jaaps.v11i1.1 · Cited by 1
Mahmood, N. M. S., Mahmood, A. M. R., & Maulood, I. M. (2025) · Cytotechnology · doi:10.1007/s10616-025-00720-y · Cited by 2
SÍNDROME METABÓLICA E DOENÇAS CARDIOVASCULARES: DO CONCEITO AO TRATAMENTO
Ferreira, M. E. (2016) · Arquivos Catarinenses de Medicina · doi:10.63845/swbssf51 · Cited by 30
Artese, H. P. C. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.23.2014.tde-19022015-113115 · Cited by 1
Sandhawalia, S. K. (2014) · University Library - University of Saskatchewan (University of Saskatchewan)
Mudau, M. (2010) · SUNScholar (Stellenbosch University) · Cited by 2
Upregulation of Renin Angiotensin Aldosterone System (RAAS) by Methylglyoxal: Role in Hypertension
Dhar, I. (2013) · University Library - University of Saskatchewan (University of Saskatchewan)
The Role of Argininosuccinate Synthase Serine 328 Phosphorylation in Nitric Oxide Production
Thompson, R. J. (2012) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Abebe, W., Baban, B., & Mozaffari, M. S. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_5
Zhou, Z. (2016) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27581778
Treatment with Thiazolidinediones
Suvag, S., Utzschneider, K. M., & Kahn, S. E. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_9
Influence of Race, Gender, Age and Diabetes on Blood Flow
PETROFSKY, J. S. (2015) · Springer eBooks · doi:10.1007/978-3-642-27814-3_61-2
Boichuk, T. М., & Savchuk, T. P. (2014) · Fìzìologìčnij žurnal · doi:10.15407/fz59.06.030
The Effect of Cardiovascular Risk Factors on the Coronary Circulation
Valenzuela-García, L. F., Matsuzawa, Y., & Lerman, A. (2017) · Springer eBooks · doi:10.1007/978-1-4471-5245-3_6
Sapalo, A. T. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-23082020-144119
Fibre optic sensors for impact-induced damage detection and assessment in composite materials
Dokos, L., Mowlem, M. C., Chambers, A. R., & Brambilla, G. (2001) · ePrints Soton (University of Southampton)
Ogiso, K., Shayo, S. C., Kawade, S., Hashiguchi, H., Deguchi, T., & Nishio, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-731463/v1
Influence of Race, Gender, Age, and Diabetes on Blood Flow
PETROFSKY, J. S. (2016) · Springer eBooks · doi:10.1007/978-3-662-47398-6_61
Ferreira, G. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-10042023-155808
Paterson, C. A. (2022) · doi:10.46289/p4s9t25l · Cited by 1
Furuya, T., Kitahama, S., Tamura, Y., Ogawa, S., Nakatani, Y., & Yasu, T. (2024) · Cureus · doi:10.7759/cureus.68561
Myocardial Revascularization in Patients with Metabolic Syndrome
Silva, N. D. S., de Andrade, B. P. G., de Souza, R. M. S., Saldanha, F. L., Amaral, D. S. D. S. R., Nelson, L. A. D. S., Sodré, M. E. J., Ventura, M. A., de Oliveira, M. W., de Souza, R. C., et al. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594962429101
Pan, Y., Fu, T., Gong, M., Sun, Q., Zhao, X., Yin, S., Cong, T., Jiang, Y., & Liu, Y. (2025) · medRxiv · doi:10.1101/2025.07.09.25331231
Augusto, S. N., Issa, R., Kaelber, D. C., & Tang, W. H. W. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103128
Taylor, P. (2013) · Otago University Research Archive (University of Otago)
Coronary Microvascular Dysfunction in Cardiovascular Disease: Diagnosis and Management
Ahmad, R., Niaz, M., Khan, S., Frangaj, K., Kumar, M., Basha, N. R., Hussain, S. S., Chettri, S., Maheta, D., Frishman, W. H., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001188
Tsiamis, N., Tsakirian, F., Papanikolaou, A., Afendoulis, D., Toulgaridis, F., Dimitriadis, K., Tolis, I., Tzortzis, S., Triantis, G., Aghayan, S., et al. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70550
Insulin resistance and ischemic stroke
Пизова, Н. В., & Pizov, A. V. (2026) · Russian neurological Journal · doi:10.30629/2658-7947-2025-30-6-4-10
Chen, G., Lou, J., Wang, J., Xie, W., Zhang, R., Zhang, C., Zhu, Y., Wu, F., Huang, J., Shao, Y., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045889
Ding, R., Su, R., Deng, Y., Niu, X., Liu, J., Wu, J., Wang, L., & Hl, Z. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02298-8
Challenges and Limitations in Targeting Oxidative Stress
Pandey, M., Pooja, Nirban, S., Roy, M., Kumari, R., Gorain, B., Jain, N., & Verma, R. K. (2026) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-032-19837-2_12
Wang, T., & Li, L. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.146020
Niu, T., Fan, L., Lian, R., Wang, F., Zhao, J., & Lin, T. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02768-4 · Cited by 1
Zhao, L., Xue, X., Li, T., Tang, C., Li, S., Tan, Z., Yan, W., Ye, M., Li, X., Liu, L., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1909900
Lee, G., Im, Y., Black, R., Kim, J., Bhoorasingh, M., Reddy, M., & Jeong, S. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00943-9
Zeng, Y., Wang, C., 黄知敏, Chen, T., Yao, F., & Zhu, W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1911136
Metadata
- Authors
- Potenza, M., Gagliardi, S., Nacci, C., Carratu, M., & Montagnani, M.
- Affiliations
- University of Bari Aldo Moro (IT)
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 94-112
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2116006961
- Cited by
- 280
- References
- 0
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 7 · 2023: 12 · 2022: 13 · 2021: 9 · 2020: 17 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 14 · 2015: 16 · 2014: 18 · 2013: 22 · 2012: 25
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- endothelial dysfunction, diabetes mellitus, nitric oxide bioavailability, reactive oxygen species, oxidative stress, advanced glycation end products, protein kinase C, insulin resistance, hyperinsulinemia, dyslipidemia, endothelin-1, adhesion molecules, vascular inflammation, PI3-kinase, MAPK signaling, diabetic vascular complications, therapeutic target
- MeSH terms
- Animals, Hypolipidemic Agents, Diabetic Angiopathies, Endothelium, Vascular, Humans, Hypoglycemic Agents, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.